| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Center for Liver, Digestive and Metabolic Diseases, Academic Hospital Groningen, Groningen University Institute for Drug Exploration, Groningen, The Netherlands
* To whom correspondence should be addressed. E-mail: a.werner{at}med.rug.nl.
Background: Essential fatty acid (EFA) deficiency in mice decreases plasma triglyceride (TG) concentrations and increases hepatic TG content. We evaluated in vivo and in vitro whether decreased hepatic secretion of TG-rich VLDL contributes to this consequence of EFA deficiency. Methods: EFA deficiency was induced in mice by feeding an EFA-deficient (EFAD) diet for 8 weeks. Hepatic VLDL secretion was quantified in fasted EFAD and EFAsufficient (EFAS) mice using the Triton WR-1339 method. In cultured hepatocytes from EFAD and EFAS mice, VLDL secretion into medium was measured by quantifying [3H]- glycerol incorporation into TG and phospholipids (PL). Hepatic expression of genes involved in VLDL synthesis and clearance was measured, as were plasma activities of lipolytic enzymes. Results: TG secretion rates were quantitatively similar in EFAD and EFAS mice in vivo and in primary hepatocytes from EFAD and EFAS mice in vitro. However, EFA deficiency increased the size of secreted VLDL particles, as determined by calculation of particle diameter, particle sizing by light scattering and evaluation of TG-to-apoB ratio. EFA deficiency did not inhibit hepatic lipase and lipoprotein lipase activities in plasma, but increased hepatic mRNA levels of apoAV and apoCII, both involved in control of lipolytic degradation of TG-rich lipoproteins. Conclusions: EFA deficiency does not affect hepatic TG secretion rate in mice, but increases the size of secreted VLDL particles. Present data suggest that hypotriglyceridemia during EFA deficiency is related to enhanced clearance of altered VLDL particles.
This article has been cited by other articles:
|
|
 |
|
  S. Lukovac, E. L. Los, F. Stellaard, E. H. H. M. Rings, and H. J. Verkade Essential fatty acid deficiency in mice impairs lactose digestion Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G605 - G613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Zivkovic, J B. German, and A. J Sanyal Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease Am. J. Clinical Nutrition, August 1, 2007; 86(2): 285 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gautier, U. J. F. Tietge, R. Boverhof, F. G. Perton, N. Le Guern, D. Masson, P. C. N. Rensen, L. M. Havekes, L. Lagrost, and F. Kuipers Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein J. Lipid Res., January 1, 2007; 48(1): 30 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. P. J. Alwayn, C. Andersson, S. Lee, D. A. Arsenault, B. R. Bistrian, K. M. Gura, V. Nose, B. Zauscher, M. Moses, and M. Puder Inhibition of matrix metalloproteinases increases PPAR-{alpha} and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1011 - G1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Werner, R. Havinga, F. Perton, F. Kuipers, and H. J. Verkade Lymphatic chylomicron size is inversely related to biliary phospholipid secretion in mice Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1177 - G1185. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
